News - Latest

95 news items

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

Sort by: Date / Relevance

Subscribe to latest news

Year-end withdrawals medicines for human use

Requests to withdraw marketing authorisations and parallel import marketing authorisations as of 31 December 2020, the so-called ...

News item | 01-09-2020 | 09:00

Conclusion of report: paracetamol is safe to use

Patients and consumers can continue to use paracetamol safely in the Netherlands. This is the conclusion of the Netherlands ...

News item | 26-08-2020 | 10:00

Safety of paracetamol is not compromised

Tonight (Thursday July 9) the Dutch newspaper NRC and TV programme Zembla published an article on contamination of paracetamol ...

News item | 09-07-2020 | 22:30

Coronavirus: consequences for applications for production and distribution licences, GMP inspections and certificates

Unfortunately, the current coronavirus situation is also having consequences for applications for licences for the manufacture ...

News item | 17-06-2020 | 09:00

Implementation of the Medical Device Regulation postponed until 26 May 2021

Due to the coronavirus crisis the European Commission has postponed the implementation of the new Medical Device Regulation (MDR, ...

News item | 08-05-2020 | 17:00

Veterinary Medicinal Products Unit: submit your application digitally

The Veterinary Medicinal Products Unit (VMPU) requests marketing authorisation holders to submit their applications or reports ...

News item | 01-05-2020 | 09:00

MEB Portal shut down permanently

For safety reasons, the MEB portal was provisionally taken offline in January this year. Unfortunately, the MEB has had to take ...

News item | 20-04-2020 | 12:00

Request to take over the Fucidin marketing authorisation

The company Leo Pharma B.V. has informed the Medicines Evaluation Board (MEB) that the production of the antibiotic Fucidin ...

News item | 31-03-2020 | 17:00

Request to take over the pyridoxine hydrochloride marketing authorisation

The company Pharmachemie B.V. has requested the Medicines Evaluation Board (MEB) to withdraw marketing authorisation for ...

News item | 30-03-2020 | 17:00

Changes to product information policy

The Medicines Evaluation Board (MEB) recently revised a number of policy documents for pharmaceutical companies relating to the ...

News item | 23-03-2020 | 12:00